See the Full Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eurovision
Baseball
Social Media
South America
Natural Disasters
European Union
Vladimir Putin
Soccer
Artificial Intelligence
Premier League
Donald Trump
Education
Published • loading... • Updated

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Summary by Charleston Gazette-Mail
WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

41 Articles

All
Left
6
Center
10
Right
5
The Courier-TribuneThe Courier-Tribune
+39 Reposted by 39 other sources
Center

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

Read Full Article
stocktitan.netstocktitan.net

Vanda Pharmaceuticals Sets Key Investor Meetings at Major Neuro & Ophthalmology Conference Next Week

Vanda executives to discuss pipeline developments and strategy at exclusive Mizuho healthcare conference. Learn about potential catalysts in neuro portfolio. Get insights.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 48% of the sources are Center
48% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States on Friday, May 16, 2025.
Sources are mostly out of (0)

Similar News Topics

Pharma

Pharma

New York State

New York State

News
For You
SearchBlindspotLocal